PROPOSURE 10 MG/ML EMULSION FOR INJECTION FOR DOGS AND CATS
PROPOSURE 10 MG/ML EMULSION FOR INJECTION FOR DOGS AND CATS
Authorised
- Propofol
Product identification
Medicine name:
PROPOSURE 10 MG/ML EMULSION FOR INJECTION FOR DOGS AND CATS
Proposure 10 mg/ml Emulsie voor injectie
Proposure 10 mg/ml Emulsion injectable
Proposure 10 mg/ml Emulsion zur Injektion
Active substance:
- Propofol
Target species:
-
Dog
-
Cat
Route of administration:
-
Intravenous use
Product details
Active substance and strength:
-
Propofol10.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Emulsion for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN01AX10
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Available in:
-
Belgium
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
- Axience
Marketing authorisation date:
Manufacturing sites for batch release:
- Corden Pharma S.p.A.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V508631
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0396/001
Concerned member states:
-
Austria
-
Belgium
-
Czechia
-
Denmark
-
Finland
-
Germany
-
Greece
-
Ireland
-
Luxembourg
-
Netherlands
-
Norway
-
Poland
-
Romania
-
Slovakia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Labelling
This document does not exist in this language (English). You can find it
in another language below.